IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v12y2015i8p8762-8772d53162.html
   My bibliography  Save this article

Long-Term Effectiveness of Antiretroviral Therapy in China: An Observational Cohort Study from 2003–2014

Author

Listed:
  • Peng Huang

    (Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 211166, China
    These authors contributed equally to this work.)

  • Jingguang Tan

    (Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China
    These authors contributed equally to this work.)

  • Wenzhe Ma

    (Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 211166, China)

  • Hui Zheng

    (Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 211166, China)

  • Yan Lu

    (Shenzhen Center for Disease Control and Prevention, Shenzhen 518055, China)

  • Ning Wang

    (National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China)

  • Zhihang Peng

    (Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 211166, China)

  • Rongbin Yu

    (Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 211166, China)

Abstract

In order to assess the effectiveness of the Chinese government’s expanded access program, a cohort study on all adult HIV patients in Shenzhen was conducted from December 2003 to February 2014 to estimate the effects of antiretroviral therapy (ART) on mortality, tuberculosis and CD4 cell counts. Marginal structural regression models adjusted for baseline and time-varying covariates. Of the 6897 patients enrolled and followed up for a maximum of 178 months, 44.92% received ART. Among patients who commenced receiving ART during the study, there were 98 deaths and 59 new tuberculosis diagnoses, while there were 410 deaths and 201 new tuberculosis diagnoses among those without ART. ART was associated with both lower mortality (hazard ratio [HR] = 0.18; 95% confidence interval [CI] = 0.11–0.27) and the presence of tuberculosis (HR = 0.27; 95% CI = 0.19–0.37). Each month of ART was associated with an average increase in CD4 cell count of 6.52 cells/µL (95% CI = 6.08–7.12 cells/µL). In conclusions, the effectiveness of ART provided by China government health services is the same as that in higher-income countries. Accounting to higher mortality rates from the delay of starting ART, faster expansion and timely imitation of ART are urgent.

Suggested Citation

  • Peng Huang & Jingguang Tan & Wenzhe Ma & Hui Zheng & Yan Lu & Ning Wang & Zhihang Peng & Rongbin Yu, 2015. "Long-Term Effectiveness of Antiretroviral Therapy in China: An Observational Cohort Study from 2003–2014," IJERPH, MDPI, vol. 12(8), pages 1-11, July.
    • Handle: RePEc:gam:jijerp:v:12:y:2015:i:8:p:8762-8772:d:53162
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/12/8/8762/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/12/8/8762/
    Download Restriction: no
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Rong Liu & Ling Huang & Qing Yang & Qiang Hu & Qing Huang & Xiaoqing Jiang & Hui Zhu & Fei Xie & Xiaotong Wen & Xiaojun Liu & Zhaokang Yuan & Yuanan Lu, 2018. "Investigation on Task Shifting of HIV/AIDS Follow-Up Management Workers in New Launched Areas, China," IJERPH, MDPI, vol. 15(10), pages 1-9, September.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:12:y:2015:i:8:p:8762-8772:d:53162. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.